Physician profile
Nighat Sarwar
NPI 1003809989
$126,631.71
in general payments reported to CMS, 2019-2025
86 companies · $9,348 in 2025
The $9,348 reported for 2025 was more than what 89% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28K · 2020: $21K · 2021: $16K · 2022: $23K · 2023: $18K · 2024: $12K · 2025: $9,348.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $18K · Food and Beverage: $17K · Travel and Lodging: $3,186 · Consulting Fee: $1,813 · Education: $131.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $17,601.00 |
| Food and Beverage | $17,246.39 |
| Travel and Lodging | $3,185.82 |
| Consulting Fee | $1,813.00 |
| Education | $131.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $77,856.75 | 2019-2025 | Vumerity, Tysabri, Tysabri |
| Emd Serono, INC. | $10,040.64 | 2019-2024 | Mavenclad |
| Alexion Pharmaceuticals, INC. | $4,052.99 | 2019-2025 | Ultomiris, Soliris |
| Genzyme Corporation | $3,940.10 | 2019-2025 | |
| Abbvie INC. | $2,721.57 | 2019-2025 | Qulipta, Ubrelvy, Botox |
| Novartis Pharmaceuticals Corporation | $2,677.05 | 2019-2025 | |
| Genentech USA, INC. | $1,584.52 | 2019-2025 | Ocrevus, Ocrevus Zunovo, Enspryng |
| Acadia Pharmaceuticals INC | $1,432.32 | 2019-2025 | Nuplazid |
| Teva Pharmaceuticals USA, INC. | $1,424.49 | 2019-2025 | Austedo Xr, Austedo Xr, Austedo |
| Ucb, INC. | $1,344.64 | 2019-2025 | Briviact, Fintepla, Rystiggo |
| Boston Scientific Corporation | $1,312.79 | 2021-2025 | Vercise, General - Dbs |
| Genentech, INC. | $1,116.32 | 2021-2025 | Ocrevus |
| Argenx US, INC. | $874.57 | 2022-2025 | Vyvgart, Vyvgart Hytrulo |
| Eisai INC. | $873.31 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $775.60 | 2019-2025 | Andexxa, Wainua |
Show all 86 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $772.74 | 2019-2022 | |
| Celgene Corporation | $748.53 | 2021-2025 | Zeposia |
| Neurocrine Biosciences, INC. | $709.50 | 2020-2025 | Ingrezza, Ongentys |
| Sk Life Science, INC. | $672.47 | 2021-2025 | Xcopri |
| Amgen INC. | $654.48 | 2019-2025 | Uplizna, Prolia, Evenity |
| Lilly USA, LLC | $623.27 | 2019-2025 | Kisunla, Amyvid, Emgality |
| Kyowa Kirin, INC. | $602.27 | 2020-2024 | Nourianz |
| Pfizer INC. | $596.97 | 2021-2025 | |
| Harmony Biosciences LLC | $567.33 | 2020-2024 | Wakix |
| Amneal Pharmaceuticals LLC | $541.04 | 2019-2024 | Rytary, Crexont |
| Jazz Pharmaceuticals INC. | $505.58 | 2019-2025 | |
| Lundbeck LLC | $502.49 | 2019-2025 | Rexulti, Vyepti |
| Janssen Pharmaceuticals, INC | $400.80 | 2021-2022 | |
| Mdd US Operations, LLC | $372.64 | 2019-2025 | Gocovri, Qelbree, Apokyn |
| Otsuka America Pharmaceutical, INC. | $362.00 | 2023-2025 | Rexulti, Nuedexta |
| Sumitomo Pharma America, INC. | $290.05 | 2023-2024 | Aptiom |
| Almatica Pharma LLC | $273.26 | 2023 | Gralise |
| Ge Healthcare | $272.19 | 2019-2025 | |
| Merz Pharmaceuticals, LLC | $271.36 | 2022-2025 | Xeomin, Ampyra, Inbrija |
| Horizon Therapeutics Plc | $255.47 | 2019-2023 | Uplizna |
| Mallinckrodt Hospital Products INC. | $245.14 | 2020-2025 | Acthar |
| Axsome Therapeutics, INC. | $237.27 | 2025 | Symbravo, Sunosi |
| Impel Pharmaceuticals INC. | $224.43 | 2022-2023 | Trudhesa |
| Banner Life Sciences, LLC | $223.39 | 2021-2024 | |
| Tg Therapeutics, INC. | $221.61 | 2023-2025 | |
| Avadel Cns Pharmaceuticals, LLC | $209.17 | 2024-2025 | Lumryz |
| Allergan, INC. | $194.59 | 2019-2022 | |
| Avanir Pharmaceuticals, INC. | $191.71 | 2019-2022 | |
| Octapharma USA, INC. | $182.57 | 2022-2025 | Panzyga |
| Livanova USA, INC. | $174.32 | 2020-2023 | Vns Therapy Sentiva Model 1000 Generator |
| Alnylam Pharmaceuticals INC. | $150.86 | 2021-2024 | Onpattro |
| Csl Behring | $146.70 | 2025 | Hizentra |
| Neurelis, INC. | $145.29 | 2020-2023 | Valtoco |
| Takeda Pharmaceuticals U.S.A., INC. | $125.50 | 2020-2025 | Hyqvia |
| Tanabe Pharma America, INC. | $117.02 | 2022-2023 | |
| Biohaven Pharmaceuticals, INC. | $113.97 | 2021 | |
| Acorda Therapeutics, INC | $109.35 | 2019-2022 | |
| Life Molecular Imaging LTD | $105.76 | 2022-2025 | Neuraceq |
| Catalyst Pharmaceuticals, INC. | $105.56 | 2020-2024 | |
| Nevro Corp. | $95.93 | 2022-2023 | Senza |
| Supernus Pharmaceuticals, INC. | $95.18 | 2019 | |
| Grifols USA, LLC | $91.44 | 2019-2025 | Gamunex-C |
| Mallinckrodt Enterprises LLC | $79.31 | 2019 | |
| Merz North America, INC. | $75.59 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $74.70 | 2022 | |
| Abbott Laboratories | $67.03 | 2019-2025 | Infinity |
| Adamas Pharmaceuticals, INC. | $61.23 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $60.92 | 2019-2021 | |
| Zogenix INC. | $57.19 | 2021 | |
| Assertio Therapeutics, INC. | $55.72 | 2019-2020 | |
| Janssen Biotech, INC. | $55.18 | 2025 | |
| Cycle Pharmaceuticals INC | $53.24 | 2025 | Tascenso Odt, Bafiertam |
| Upsher-Smith Laboratories LLC | $51.77 | 2020-2022 | |
| Scilex Pharmaceuticals INC. | $44.62 | 2023-2024 | Ztlido |
| Azurity Pharmaceuticals, INC. | $31.40 | 2023-2024 | Horizant, Horizant |
| Ani Pharmaceuticals, INC. | $31.34 | 2024 | Purified Cortrophin Gel |
| Bayer Healthcare Pharmaceuticals INC. | $29.27 | 2019-2020 | |
| Tersera Therapeutics LLC | $27.45 | 2022 | |
| Mylan Specialty L.P. | $26.74 | 2023 | Glatiramer Acetate |
| Sandoz INC. | $25.97 | 2024 | |
| Ipsen Biopharmaceuticals, INC | $24.05 | 2022 | |
| Tonix Medicines, INC. | $23.20 | 2025 | Zembrace Symtouch |
| E.R. Squibb & Sons, L.L.C. | $23.05 | 2020 | |
| Zyla Life Sciences, INC. | $19.53 | 2019 | |
| Avion Pharmaceuticals | $19.02 | 2022 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $16.56 | 2024 | Rexulti |
| Tactile Systems Technology INC | $15.94 | 2021 | |
| Cala Health, INC. | $14.38 | 2023 | Cala Trio |
| Arbor Pharmaceuticals, INC. | $13.71 | 2019 | |
| Angiodynamics, INC. | $12.87 | 2022 | |
| Merck Sharp & Dohme LLC | $11.87 | 2019 |
Drugs and devices associated with these payments
Vumerity $12KTysabri $9,235Ultomiris $3,213Vercise $1,099Nuplazid $922Kesimpta $885Qulipta $827Leqembi $797Austedo Xr $659Zeposia $657Ubrelvy $621Ingrezza $571Ocrevus $563Nurtec Odt $552Rexulti $550Zavzpret $490Vyvgart $407Vyvgart Hytrulo $381Botox $381Briviact $317Fintepla $301Andexxa $294Aptiom $290Gralise $273Briumvi $222Symbravo $216Lumryz $209Ocrevus Zunovo $203Ongentys $197Rytary $189Gocovri $182Uplizna $176Panzyga $159Wakix $158Hizentra $147Xeomin $144Kisunla $141Nourianz $137Bafiertam $129Vraylar $129Paxlovid $100Nuedexta $96.81General - Dbs $91.65Austedo $91.25Neuraceq $90.57Rystiggo $90.16Amyvid $88.40Hyqvia $86.44Epidiolex $84.85Fycompa $82.55Duopa $80.78Comirnaty $79.74Onpattro $77.95Vns Therapy Sentiva Model 1000 Generator $74.33Radicava Ors $69.23Radicava $69.23Nayzilam $66.93Vyepti $63.97Enspryng $61.17Xywav $57.50Avonex $56.26Tascenso Odt $53.24Qelbree $51.41Skyclarys $50.80Plegridy $43.49Apokyn $42.81Trudhesa $42.01Infinity $41.52Valtoco $38.72Wainua $37.27Horizant $31.40Purified Cortrophin Gel $31.34Mavenclad $29.07Crexont $27.95Glatiramer Acetate $26.74Gamunex-C $25.80Aduhelm $25.22Elyxyb - Celecoxib $23.34Zembrace Symtouch $23.20Ampyra $23.05Inbrija $23.05Soliris $22.72Aubagio $22.32Vyalev $21.63Sunosi $21.43Ztlido $21.28Xcopri $21.25Evenity $20.59Prolia $20.59Senza $19.81Leqvio $19.60Acthar $18.16Emgality $15.83Cala Trio $14.38Xolair $13.00
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nighat Sarwar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.